1. Home
  2. BMEA vs STKS Comparison

BMEA vs STKS Comparison

Compare BMEA & STKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMEA
  • STKS
  • Stock Information
  • Founded
  • BMEA 2017
  • STKS 2004
  • Country
  • BMEA United States
  • STKS United States
  • Employees
  • BMEA N/A
  • STKS N/A
  • Industry
  • BMEA Biotechnology: Pharmaceutical Preparations
  • STKS Restaurants
  • Sector
  • BMEA Health Care
  • STKS Consumer Discretionary
  • Exchange
  • BMEA Nasdaq
  • STKS Nasdaq
  • Market Cap
  • BMEA 125.4M
  • STKS 100.6M
  • IPO Year
  • BMEA 2021
  • STKS N/A
  • Fundamental
  • Price
  • BMEA $2.00
  • STKS $3.03
  • Analyst Decision
  • BMEA Buy
  • STKS Buy
  • Analyst Count
  • BMEA 13
  • STKS 2
  • Target Price
  • BMEA $27.92
  • STKS $4.25
  • AVG Volume (30 Days)
  • BMEA 636.9K
  • STKS 73.8K
  • Earning Date
  • BMEA 05-01-2025
  • STKS 05-06-2025
  • Dividend Yield
  • BMEA N/A
  • STKS N/A
  • EPS Growth
  • BMEA N/A
  • STKS N/A
  • EPS
  • BMEA N/A
  • STKS N/A
  • Revenue
  • BMEA N/A
  • STKS $673,344,000.00
  • Revenue This Year
  • BMEA $191.34
  • STKS $27.68
  • Revenue Next Year
  • BMEA N/A
  • STKS $3.27
  • P/E Ratio
  • BMEA N/A
  • STKS N/A
  • Revenue Growth
  • BMEA N/A
  • STKS 102.35
  • 52 Week Low
  • BMEA $1.94
  • STKS $2.37
  • 52 Week High
  • BMEA $14.43
  • STKS $6.10
  • Technical
  • Relative Strength Index (RSI)
  • BMEA 28.47
  • STKS 54.19
  • Support Level
  • BMEA $2.27
  • STKS $2.85
  • Resistance Level
  • BMEA $3.08
  • STKS $3.11
  • Average True Range (ATR)
  • BMEA 0.23
  • STKS 0.17
  • MACD
  • BMEA 0.00
  • STKS 0.05
  • Stochastic Oscillator
  • BMEA 2.95
  • STKS 89.19

About BMEA Biomea Fusion Inc.

Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.

About STKS The ONE Group Hospitality Inc.

The One Group Hospitality Inc is a restaurant company that develops, owns and operates, manages and licenses upscale and polished casual, high-energy restaurants and lounges and provides turn-key food and beverage (F&B) services for hospitality venues, including hotels, casinos, and other high-end locations internationally. The company operates through four segments: STK, Kona Grill, ONE Hospitality, and Corporate. The company generates the vast majority of its revenue from the domestic market.

Share on Social Networks: